Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 40 of 1714:
30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type IV, beta DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase ZAFIRLUKAST HMG-CoA Reductase 67% NoneNone NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase ZAFIRLUKAST HMG-CoA Reductase 67% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase KETOTIFEN CYP450-2D6 Inhibition 67% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) ALOSETRON CYP450-2C9 Inhibition 67% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 ALOSETRON CYP450-2C9 Inhibition 67% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) CHLORMADINONE ACETATE CYP450-2C9 Inhibition 67% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 CHLORMADINONE ACETATE CYP450-2C9 Inhibition 67% NoneNone NoneNone View
acetylcholinesterase (YT blood group) 4-NONYLPHENOL Acetylcholinesterase 67% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase 4-NONYLPHENOL Acetylcholinesterase 67% NoneNone NoneNone View
acetylcholinesterase 4-NONYLPHENOL Acetylcholinesterase 67% NoneNone NoneNone View
adenosine A2a receptor AMINOPHYLLINE Adenosine A2A 67% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) METHYLERGONOVINE Adrenergic alpha1D 67% NoneNone NoneNone View
adrenergic receptor, alpha 2b AMITRAZ Adrenergic alpha2B 67% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 GRAMICIDIN Adrenergic, Norepinephrine Transporter 67% NoneNone NoneNone View
bradykinin receptor, beta 2 GRAMICIDIN Bradykinin B2 67% NoneNone NoneNone View
bradykinin receptor B2 GRAMICIDIN Bradykinin B2 67% NoneNone NoneNone View
adrenergic receptor, alpha 2a MOXONIDINE Adrenergic alpha2A 67% NoneNone NoneNone View
A3 adenosine receptor DIGITONIN Adenosine A3 67% NoneNone NoneNone View
adrenergic receptor, alpha 2b O-ANISIDINE Adrenergic alpha2B 67% 2.508uM 1.145uM View
neuropeptide Y receptor Y2 DIHYDROERGOCRISTINE MESYLATE Neuropeptide Y2 67% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
adrenergic receptor, alpha 2b EPERISONE Adrenergic alpha2B 71% 3.034uM 1.385uM View
adrenergic receptor, beta 1 BROMOCRIPTINE Adrenergic beta1 71% 2.4uM 1.386uM View
adrenergic, beta-1-, receptor BROMOCRIPTINE Adrenergic beta1 71% 2.4uM 1.386uM View
histamine receptor H 1 CITALOPRAM Histamine H1, Central 71% 3.194uM .371uM View
adrenergic receptor, alpha 2a VERAPAMIL Imidazoline I2, Central 71% 5.524uM 3.683uM View
adrenergic receptor, alpha 2c (Non-specific probe) VERAPAMIL Imidazoline I2, Central 71% 5.524uM 3.683uM View
adrenergic receptor, alpha 1b LYSERGOL Adrenergic alpha1B 71% 4.726uM 2.616uM View
sodium channel, nonvoltage-gated 1, delta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, nonvoltage-gated 1 alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type X, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type IX, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage gated, type VIII, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type VII, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type IV, beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type IV, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type III, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type II, beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type II, alpha 2 PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type I, beta PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
sodium channel, voltage-gated, type I, alpha PYRILAMINE Sodium Channel, Site 2 71% 5.283uM 4.819uM View
A3 adenosine receptor NELFINAVIR Adenosine A3 71% 14.796uM 8.363uM View
adrenergic receptor, alpha 1a TACRINE Adrenergic alpha1A 71% 2.749uM 1.113uM View
adrenergic receptor, beta 2 ZIDOVUDINE Adrenergic beta2 12% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 PROCHLORPERAZINE Dopamine Transporter 71% 1.735uM 1.379uM View
monoamine oxidase A PIOGLITAZONE Monoamine Oxidase MAOA 71% 35.069uM NoneNone View
monoamine oxidase A PIOGLITAZONE Monoamine Oxidase MAOA 71% 35.069uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A PIPAMAZINE Serotonin 5-HT1A 71% 1.782uM 1.018uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) GW-1929 CYP450-2C9 Inhibition 71% 4uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 GW-1929 CYP450-2C9 Inhibition 71% 4uM NoneNone View
epidermal growth factor receptor GW-1929 Protein Tyrosine Kinase, EGF Receptor 71% 10.896uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 7 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 6 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 5 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 4 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 3 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 2 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, gamma subunit 1 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, beta 4 subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, beta 3 subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, beta 2 subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, alpha 1F subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, beta 1 subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 MICONAZOLE Calcium Channel Type L, Benzothiazepine 71% 18.034uM 16.03uM View
sodium channel, nonvoltage-gated 1 alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel associated protein 1 AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C CHLOROXYLENOL Serotonin 5-HT2C 69% NoneNone NoneNone View
nuclear receptor subfamily 3, group C, member 1 PREGNENOLONE-16ALPHA-CARBONITRILE Glucocorticoid 69% 13.957uM 6.344uM View
adrenergic receptor, alpha 1b ERGONOVINE Adrenergic alpha1B 69% NoneNone NoneNone View
androgen receptor FLUOCINONIDE Testosterone 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit FLUOXETINE Calcium Channel Type L, Dihydropyridine 69% NoneNone NoneNone View
epidermal growth factor receptor FLUPHENAZINE Protein Tyrosine Kinase, EGF Receptor 69% 40.107uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit DOXEPIN Calcium Channel Type L, Benzothiazepine 69% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DEXTROMETHORPHAN Calcium Channel Type L, Benzothiazepine 66% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 LABETALOL Serotonin Transporter 66% NoneNone NoneNone View
adrenergic receptor, beta 2 BROMOCRIPTINE Adrenergic beta2 66% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 ISOEUGENOL Cyclooxygenase COX-1 66% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) ISOEUGENOL Cyclooxygenase COX-1 66% NoneNone NoneNone View
chemokine (C-C motif) receptor 2 CISPLATIN Chemokine CCR2B 66% 18.142uM 7.012uM View
5-hydroxytryptamine (serotonin) receptor 2A LOPERAMIDE Serotonin 5-HT2A 66% NoneNone NoneNone View
A3 adenosine receptor N,N'-DIPHENYL-P-PHENYLENEDIAMINE Adenosine A3 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 ITRACONAZOLE Calcium Channel Type L, Dihydropyridine 66% NoneNone NoneNone View
Sigma-2 Receptor IRINOTECAN Sigma2 66% NoneNone NoneNone View
adrenergic receptor, alpha 2a IMIQUIMOD Adrenergic alpha2A 66% NoneNone NoneNone View
opioid receptor, kappa 1 RITONAVIR Opiate kappa 66% 13.655uM 5.462uM View
Sigma-2 Receptor NORETHINDRONE ACETATE Sigma2 66% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) OXICONAZOLE Protein Tyrosine Kinase, HER2 Receptor 66% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) OXICONAZOLE Protein Tyrosine Kinase, HER2 Receptor 66% NoneNone NoneNone View
mitogen activated protein kinase 14 EPALRESTAT Protein Serine/Threonine Kinase, p38alpha 66% NoneNone NoneNone View
mitogen-activated protein kinase 14 EPALRESTAT Protein Serine/Threonine Kinase, p38alpha 66% NoneNone NoneNone View
opioid receptor, sigma 1 ORPHENADRINE Sigma1 66% NoneNone NoneNone View
arachidonate 15-lipoxygenase, second type RESVERATROL Lipoxygenase 15-LO 66% NoneNone NoneNone View
arachidonate 15-lipoxygenase RESVERATROL Lipoxygenase 15-LO 66% NoneNone NoneNone View
arachidonate 15-lipoxygenase RESVERATROL Lipoxygenase 15-LO 66% NoneNone NoneNone View
Sigma-2 Receptor CETYLPYRIDINIUM BROMIDE Sigma2 66% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 RALOXIFENE Muscarinic M5 66% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 DIPHENHYDRAMINE Dopamine Transporter 66% NoneNone NoneNone View
mu-opioid receptor MOR HALOPROGIN Opiate mu 66% NoneNone NoneNone View
chemokine (C-C motif) receptor 5 DISULFIRAM Chemokine CCR5 66% 23.661uM 18.284uM View
ATPase, Na+/K+ transporting, beta 1 polypeptide MICONAZOLE ATPase, Na+/K+ 66% 19.279uM NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide MICONAZOLE ATPase, Na+/K+ 66% 19.279uM NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide MICONAZOLE ATPase, Na+/K+ 66% 19.279uM NoneNone View
histamine receptor H 2 DEXCHLORPHENIRAMINE Histamine H2 71% 8.368uM 8.228uM View
thromboxane A synthase 1 ERGOCORNINE Thromboxane Synthetase 71% 1.993uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) ERGOCORNINE Thromboxane Synthetase 71% 1.993uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A SULCONAZOLE Serotonin 5-HT2A 71% 3.929uM 1.122uM View
5-hydroxytryptamine (serotonin) receptor 2C SULCONAZOLE Serotonin 5-HT2C 71% 2.785uM 1.459uM View
Cytochrom P450-2C19 monooxygenase MC 258714 CYP450-2C19 Inhibition 71% 3uM NoneNone View
Cytochrom P450-2D6 monooxygenase CELECOXIB CYP450-2D6 Inhibition 71% 1uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C U-78517F Serotonin 5-HT2C 71% 7.563uM 3.962uM View
cholinergic receptor, muscarinic 2 AMOXAPINE Muscarinic M2 71% 2.623uM .933uM View
endothelin receptor type A AMIODARONE Endothelin ETA 71% 26.288uM 16.177uM View